Fierce Biotech5d
Orca's cell therapy trounces traditional care in blood cancer phase 3, swimming into space's 'holy grail'
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
China’s Hesai denies short-seller claims on revenues and military ties
China’s Hesai has denied short-seller allegations that the world’s biggest maker of laser sensors for electric vehicles has ...